A pilot trial evaluating efficacy of everolimus/sorafenib combination in children and adolescents with refractory osteosarcoma
Latest Information Update: 21 Jul 2016
At a glance
- Drugs Everolimus (Primary) ; Sorafenib (Primary)
- Indications Osteosarcoma
- Focus Therapeutic Use
- 21 Jul 2016 New trial record
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology